AIM:To evaluate clinical outcomes of unilateral implantation of a diffractive multifocal intraocular lens(IOL)in patients with contralateral monofocal IOL.METHODS:Twenty-two patients who already had implantation of a ...AIM:To evaluate clinical outcomes of unilateral implantation of a diffractive multifocal intraocular lens(IOL)in patients with contralateral monofocal IOL.METHODS:Twenty-two patients who already had implantation of a monofocal IOL in unilateral eye underwent implantation of a diffractive multifocal IOL in contralateral eye were enrolled.After 1,6,and 12 mo,uncorrected and distant corrected distant visual acuity(UCDVA and DCDVA),uncorrected and distant corrected intermediate-visual acuity(UCIVA and DCIVA),uncorrected and distant corrected near visual acuity(UCNVA and DCNVA),and contrast sensitivity were obtained.Halo/glare symptoms,spectacle dependence,and patient satisfaction were also evaluated.RESULTS:The mean age was 67.86±7.25 y and the average interval between two IOL implantations was 645.82±878.44 d.At 1 mo,binocular UCDVA was lower than 0.20 logMAR in 76%of patients(mean 0.12±0.13 logMAR),which increased to 90%by 6 and 12 mo.The binocular UCDVA was significantly better than the monocular results(P<0.05)at 1,6,and 12 mo.Additionally,UCNVA was lower than 0.40 logMAR in 82%of patients,increasing to 90%by 6 and 12 mo.Mean UCNVA in the multifocal IOL implanted eye was statistically significantly better than that in the monofocal IOL implanted eye(P<0.05)at 1,6,and 12 mo.About 5%of patients at 1 and 6 mo,reported"severe glare or halo".Patient satisfaction rates were 95%and 91%at 6 and 12 mo,respectively.CONCLUSION:Unilateral implantation of multifocal IOL in patients with a contralateral,monofocal IOL implantation results in high patient satisfaction rate,with low severe glare or halo rate during follow-up.It can represent a good option for patients who have previously had a monofocal IOL implantation regardless of two year interval duration between two IOL implantations.展开更多
AIM：To evaluate clinical outcomes after implantation of a new diffractive aspheric multifocal intraocular lens（IOL） with ＋3.00 addition power.METHODS：This is a retrospective,consecutive case series of cataract pa...AIM：To evaluate clinical outcomes after implantation of a new diffractive aspheric multifocal intraocular lens（IOL） with ＋3.00 addition power.METHODS：This is a retrospective,consecutive case series of cataract patients who underwent bilateral implantation of the Optiflex MO/HF D012（Moss Vision Inc.Ltd,London,UK） multifocal IOL.Patients followed for 6 mo were included in the study.Data on distance,intermediate and near visual acuity,refractive error [manifest spherical equivalent（MSE）],contrast sensitivity,adverse events,subjective symptoms,spectacle independence and patient satisfaction [visual function questionnaire（VFQ）-25 questionnaire] were retrieved from electronic medical records and analyzed.RESULTS：Forty eyes of 20 patients with a mean age of 66.7±8.5 y（range：53-82） were included in the study.Mean uncorrected distance,near and intermediate visual acuity remained stable through postoperative visits and was 0.19±0.19 log MAR,Jaeger 4 and Jaeger 3 respectively at the 6 mo visit.At the end of postoperative 6 mo,MSE was-0.14±0.42 diopters（D） and 98% of the eyes were within 1.00 D of target refraction.Postoperative low contrast（10%） visual acuity remained stable（P=0.54） through follow up visits with a mean of 0.35±0.17 log MAR at the 6 mo visit.There were no reported adverse events.None of the patients reported subjective symptoms of halo or glare.Spectacle independence rate was 90%.Mean VFQ-25 questionnaire score was 93.5±6.12.CONCLUSION：The Optiflex MO/HF-DO12 IOL was safely implanted and successfully restored distance,intermediate and near visual acuity without impairing contrast sensitivity.High levels of spectacle independence were achieved at all distances including intermediate distance.展开更多
AIM:To evaluate clinical outcomes following implantation of an extended range of vision intraocular lens(IOL),the ZXR00,and a diffractive multifocal IOL with+2.75 diopters(D)add power,the ZKB00.METHODS:Totally 30 pati...AIM:To evaluate clinical outcomes following implantation of an extended range of vision intraocular lens(IOL),the ZXR00,and a diffractive multifocal IOL with+2.75 diopters(D)add power,the ZKB00.METHODS:Totally 30 patients who underwent either bilateral implantation of the ZXR00 IOL with intended emmetropia(ZXR00 emmetropia group:20 eyes)and intended micromonovision(ZXR00 monovision group:20 eyes),or bilateral implantation of the ZKB00 IOL with intended emmetropia(ZKB00 group:20 eyes)were included in this study.Visual acuity at 4 m,80,and 40 cm;and the types of halos(misty,fine,and rainbow)were analyzed at one and three months after surgery.RESULTS:There were no significant differences in distance visual acuity among the three groups.The mean uncorrected intermediate visual acuity was better in the ZXR00 emmetropia and monovision groups(0.02 logMAR and 0.02 logMAR,respectively)than in the ZKB00 group(0.14 logMAR).The mean uncorrected near visual acuity was worse in the ZXR00 emmetropia group(0.26 logMAR)than in the ZXR00 monovision and ZKB00 groups(0.12 logMAR and 0.10 logMAR,respectively).There was an increased incidence of rainbow halos in the ZKB00 group vs in either ZXR00 group(P=0.033).CONCLUSION:Implantation of the ZXR00 IOL with intended micromonovision provide superior visual acuity than implantation of the ZXR00 IOL with intended emmetropia.The ZXR00 IOLs tend to show a lower incidence of rainbow halos than did the ZKB00 IOL.展开更多
目的评价传导性角膜热成形术（CK）治疗衍射型多焦点人工晶状体植入术后正性屈光不正的临床效果。方法回顾性病例研究。6例（7眼）植入衍射型多焦点人工晶状体后发生正性屈光不正的患者接受CK手术，手术采用CK View Point Refractec（RC...目的评价传导性角膜热成形术（CK）治疗衍射型多焦点人工晶状体植入术后正性屈光不正的临床效果。方法回顾性病例研究。6例（7眼）植入衍射型多焦点人工晶状体后发生正性屈光不正的患者接受CK手术，手术采用CK View Point Refractec（RCS-200,Refractec,Inc.）系统。随访1年，观察患者远近视力、最佳矫正视力、脱镜率、屈光状态、角膜曲率等指标。CK手术前和术后1年远、近视力变化采用非参数秩和检验。结果CK手术前患者中位数远视力为0．4，中位数近视力为0．25，平均等效球镜＋1．10±0．29D（＋0．75-＋1．50D）。CK术后1年，患者的中位数远视力为0．8，中位数近视力为0．5．平均等效球镜为-0．39±0．38D（＋0．25--1．0D）。CK术后1年，患者远、近视力，与术前相比差异具有统计学意义（Z=-2．226，-2．375，P〈0．05）。结论CK可以安全有效地治疗白内障手术后轻度正性屈光不正。并且能提高衍射型多焦点人工晶状体植入术后的脱镜率。展开更多
基金Supported by the Student Research Grant of University of Ulsan College of Medicine,Seoul,Korea(No.17-18)Grant from the Asan Institute for Life Sciences,Seoul,Korea(No.2014-464)。
文摘AIM:To evaluate clinical outcomes of unilateral implantation of a diffractive multifocal intraocular lens(IOL)in patients with contralateral monofocal IOL.METHODS:Twenty-two patients who already had implantation of a monofocal IOL in unilateral eye underwent implantation of a diffractive multifocal IOL in contralateral eye were enrolled.After 1,6,and 12 mo,uncorrected and distant corrected distant visual acuity(UCDVA and DCDVA),uncorrected and distant corrected intermediate-visual acuity(UCIVA and DCIVA),uncorrected and distant corrected near visual acuity(UCNVA and DCNVA),and contrast sensitivity were obtained.Halo/glare symptoms,spectacle dependence,and patient satisfaction were also evaluated.RESULTS:The mean age was 67.86±7.25 y and the average interval between two IOL implantations was 645.82±878.44 d.At 1 mo,binocular UCDVA was lower than 0.20 logMAR in 76%of patients(mean 0.12±0.13 logMAR),which increased to 90%by 6 and 12 mo.The binocular UCDVA was significantly better than the monocular results(P<0.05)at 1,6,and 12 mo.Additionally,UCNVA was lower than 0.40 logMAR in 82%of patients,increasing to 90%by 6 and 12 mo.Mean UCNVA in the multifocal IOL implanted eye was statistically significantly better than that in the monofocal IOL implanted eye(P<0.05)at 1,6,and 12 mo.About 5%of patients at 1 and 6 mo,reported"severe glare or halo".Patient satisfaction rates were 95%and 91%at 6 and 12 mo,respectively.CONCLUSION:Unilateral implantation of multifocal IOL in patients with a contralateral,monofocal IOL implantation results in high patient satisfaction rate,with low severe glare or halo rate during follow-up.It can represent a good option for patients who have previously had a monofocal IOL implantation regardless of two year interval duration between two IOL implantations.
文摘AIM：To evaluate clinical outcomes after implantation of a new diffractive aspheric multifocal intraocular lens（IOL） with ＋3.00 addition power.METHODS：This is a retrospective,consecutive case series of cataract patients who underwent bilateral implantation of the Optiflex MO/HF D012（Moss Vision Inc.Ltd,London,UK） multifocal IOL.Patients followed for 6 mo were included in the study.Data on distance,intermediate and near visual acuity,refractive error [manifest spherical equivalent（MSE）],contrast sensitivity,adverse events,subjective symptoms,spectacle independence and patient satisfaction [visual function questionnaire（VFQ）-25 questionnaire] were retrieved from electronic medical records and analyzed.RESULTS：Forty eyes of 20 patients with a mean age of 66.7±8.5 y（range：53-82） were included in the study.Mean uncorrected distance,near and intermediate visual acuity remained stable through postoperative visits and was 0.19±0.19 log MAR,Jaeger 4 and Jaeger 3 respectively at the 6 mo visit.At the end of postoperative 6 mo,MSE was-0.14±0.42 diopters（D） and 98% of the eyes were within 1.00 D of target refraction.Postoperative low contrast（10%） visual acuity remained stable（P=0.54） through follow up visits with a mean of 0.35±0.17 log MAR at the 6 mo visit.There were no reported adverse events.None of the patients reported subjective symptoms of halo or glare.Spectacle independence rate was 90%.Mean VFQ-25 questionnaire score was 93.5±6.12.CONCLUSION：The Optiflex MO/HF-DO12 IOL was safely implanted and successfully restored distance,intermediate and near visual acuity without impairing contrast sensitivity.High levels of spectacle independence were achieved at all distances including intermediate distance.
基金Supported by the Basic Science Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Science and ICT(No.2018R1C1B6002794)Korea University Grant(No.K1625491,No.K1722121,No.K1811051)。
文摘AIM:To evaluate clinical outcomes following implantation of an extended range of vision intraocular lens(IOL),the ZXR00,and a diffractive multifocal IOL with+2.75 diopters(D)add power,the ZKB00.METHODS:Totally 30 patients who underwent either bilateral implantation of the ZXR00 IOL with intended emmetropia(ZXR00 emmetropia group:20 eyes)and intended micromonovision(ZXR00 monovision group:20 eyes),or bilateral implantation of the ZKB00 IOL with intended emmetropia(ZKB00 group:20 eyes)were included in this study.Visual acuity at 4 m,80,and 40 cm;and the types of halos(misty,fine,and rainbow)were analyzed at one and three months after surgery.RESULTS:There were no significant differences in distance visual acuity among the three groups.The mean uncorrected intermediate visual acuity was better in the ZXR00 emmetropia and monovision groups(0.02 logMAR and 0.02 logMAR,respectively)than in the ZKB00 group(0.14 logMAR).The mean uncorrected near visual acuity was worse in the ZXR00 emmetropia group(0.26 logMAR)than in the ZXR00 monovision and ZKB00 groups(0.12 logMAR and 0.10 logMAR,respectively).There was an increased incidence of rainbow halos in the ZKB00 group vs in either ZXR00 group(P=0.033).CONCLUSION:Implantation of the ZXR00 IOL with intended micromonovision provide superior visual acuity than implantation of the ZXR00 IOL with intended emmetropia.The ZXR00 IOLs tend to show a lower incidence of rainbow halos than did the ZKB00 IOL.
文摘目的评价传导性角膜热成形术（CK）治疗衍射型多焦点人工晶状体植入术后正性屈光不正的临床效果。方法回顾性病例研究。6例（7眼）植入衍射型多焦点人工晶状体后发生正性屈光不正的患者接受CK手术，手术采用CK View Point Refractec（RCS-200,Refractec,Inc.）系统。随访1年，观察患者远近视力、最佳矫正视力、脱镜率、屈光状态、角膜曲率等指标。CK手术前和术后1年远、近视力变化采用非参数秩和检验。结果CK手术前患者中位数远视力为0．4，中位数近视力为0．25，平均等效球镜＋1．10±0．29D（＋0．75-＋1．50D）。CK术后1年，患者的中位数远视力为0．8，中位数近视力为0．5．平均等效球镜为-0．39±0．38D（＋0．25--1．0D）。CK术后1年，患者远、近视力，与术前相比差异具有统计学意义（Z=-2．226，-2．375，P〈0．05）。结论CK可以安全有效地治疗白内障手术后轻度正性屈光不正。并且能提高衍射型多焦点人工晶状体植入术后的脱镜率。
